Skip to content
Every investor in Lowe's Companies, Inc. (NYSE:LOW) should be aware of the most powerful shareholder groups......
Centers for Disease Control Director Robert Redfield on Friday forcefully advocated the reopening of U.S. schools, even as colleges and universities around the country have been forced to shut their doors prematurely ahead of the fall session, in order to contain a rise in COVID-19 infections. The centers followed strict guidelines and tested kids and adults daily or regularly....
Gerber Kawasaki Wealth and Investment Management CEO Ross Gerber joins Yahoo Finance's Akiko Fujita to discuss what's ahead for Tesla as the automaker's stock reaches another record high....
Gerber Kawasaki Wealth and Investment Management CEO Ross Gerber joins Yahoo Finance's Akiko Fujita to discuss what's ahead for Tesla as the automaker's stock reaches another record high....
With revised federal hours of service scheduled to take effect Sept. 29, ELD providers have also been planning how best to assist fleets with the changes. ...
Recent times have not been rewarding for investors of vaccine maker Inovio (INO). Over the past two months, shares have declined by a depressing 48%. However, zoom out and a different picture emerges. Despite the recent drop, since the turn of the year, the stock is up by a very impressive 325%.Which presents investors with a conundrum. Does the recent pullback present an opportunity to get in at a discount or has time already passed for this small cap biotech?Well, Inovio remains a high-risk company, and if you’re not a risk taker you may want to monitor its progress from the sidelines. At least that's the approach of RBC analyst Gregory Renza. After virtual meetings with Inovio management, Renza noted, "We are encouraged by management's high confidence in ongoing clinical execution and external funding prospects to accelerate INO-4800 development,” Renza said. “Though we believe several unanswered but natural questions continue to...
It is not uncommon to see companies perform well in the years after insiders buy shares. Unfortunately, there are also......
